A disappointing phase 3 study last year prompted Novo Nordisk to drop the blood pressure candidate ocedurenone.
发布者：BY CHRISTOPHER DUE KARLSSON，转转请注明出处：https://robotalks.cn/novo-nordisk-seeks-million-dollar-damages-following-failed-acquisition/
Novo Nordisk seeks million-dollar damages following failed acquisition
赞 (0)
关于作者
相关推荐
-
NeuroFlow acquires, integrates Intermountain’s behavioral health analytics model
The well being system’s proprietary mannequin gives a clinically validated method to figuring out behavioral well being patterns and danger stratification to assist informati…
-
Rackspace demonstrates impressive efficiency gains, sending its stock way higher
Shares of Rackspace Expertise Inc. hit a sizzling streak right now, rising throughout the common buying and selling interval after which accelerating after the corporate posted its…
-
Electric cars overtake petrol models in Norway
Scorching on the heels of still-dominant diesel automobiles, electrical automobiles now outnumber petrol fashions for the primary time in oil-rich Norway, a world first that places…
-
Supply Chain & Logistics News January 20th – January 23rd
Hello There! Invite to the brand-new age of the USA! Today the 47th Head of state, Donald Trump was vowed in. Within his initial week, the management has actually elevated some iss…
-
Nintendo gets dark with detective game Emio
Picture: Nintendo Sure, it’s not straight-up scary as the early teasers suggested, however also still, Emio — The Smiling Man is amongst the darkest video games Nintendo has …
